The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation.
Saved in:
| Title: | The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation. |
|---|---|
| Authors: | Albor C; King's College Hospital NHS Foundation Trust, London, UK. c.albor@nhs.net.; Royal Free London NHS Foundation Trust, London, UK. c.albor@nhs.net., Anyiam O; University Hospitals of Derby & Burton NHS Foundation Trust, Derby, UK., Boyle LD; Department of Endocrinology, Centre for Obesity, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT2, UK.; Barts Health NHS Trust, West Smithfield, London, EC1A 7BE, UK., Makaronidis J; Department of Diabetes and Metabolism, Royal London Hospital, Barts Health NHS Trust, London, UK.; National Institute of Health Research, UCLH Biomedical Research Centre, London, UK.; Centre for Obesity Research, Department of Medicine, Rayne Institute, University College London, London, UK., Tan R; King's College Hospital NHS Foundation Trust, London, UK., Iftikhar S; Royal Surrey Hospital NHS Trust, Guildford, UK., Burzic A; Division of Medicine, University of Nottingham, Nottingham, NG5 1PB, UK., Lajeunesse Trempe F; Institut Universitaire de Cardiologie Et de Pneumologie de Québec, Québec, QC, Canada.; Faculty of Pharmacy, Laval University, Quebec, QC, Canada., Stanley M; Helier Hospital, Sutton, UK., Bhatti A; Nottingham University Hospitals, University of Nottingham, Nottingham, UK., Scragg J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Badawy L; Royal Free London NHS Foundation Trust, London, UK., Moqeem K; Kings College Hospital, London, UK., Idris I; University of Nottingham, Nottingham, UK.; University Hospitals of Derby & Burton FT, Derby, UK., Andrews RC; University of Exeter Medical School, Exeter, UK., Sen Gupta P; Guy's and St Thomas's Hospitals NHS Trust, King's College London, London, UK., Hughes D; University Hospitals of Derby & Burton FT, Derby, UK., McCullough K; Royal Surrey Hospital NHS Trust, Guildford, UK.; Ashford and St Peter's Hospital NHS Trust, Surrey, UK.; Royal College of Physicians, London, UK.; NHS England, London, UK., Tan T; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, W12 0HS, UK., McGowan B; Guy's and St Thomas's Hospitals NHS Trust, King's College London, London, UK. |
| Source: | Current obesity reports [Curr Obes Rep] 2026 Apr 02; Vol. 15 (1). Date of Electronic Publication: 2026 Apr 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Medicine Group Country of Publication: United States NLM ID: 101578283 Publication Model: Electronic Cited Medium: Internet ISSN: 2162-4968 (Electronic) Linking ISSN: 21624968 NLM ISO Abbreviation: Curr Obes Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41922811 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Albor+C%22">Albor C</searchLink>; King's College Hospital NHS Foundation Trust, London, UK. c.albor@nhs.net.; Royal Free London NHS Foundation Trust, London, UK. c.albor@nhs.net.<br /><searchLink fieldCode="AU" term="%22Anyiam+O%22">Anyiam O</searchLink>; University Hospitals of Derby & Burton NHS Foundation Trust, Derby, UK.<br /><searchLink fieldCode="AU" term="%22Boyle+LD%22">Boyle LD</searchLink>; Department of Endocrinology, Centre for Obesity, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT2, UK.; Barts Health NHS Trust, West Smithfield, London, EC1A 7BE, UK.<br /><searchLink fieldCode="AU" term="%22Makaronidis+J%22">Makaronidis J</searchLink>; Department of Diabetes and Metabolism, Royal London Hospital, Barts Health NHS Trust, London, UK.; National Institute of Health Research, UCLH Biomedical Research Centre, London, UK.; Centre for Obesity Research, Department of Medicine, Rayne Institute, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Tan+R%22">Tan R</searchLink>; King's College Hospital NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Iftikhar+S%22">Iftikhar S</searchLink>; Royal Surrey Hospital NHS Trust, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Burzic+A%22">Burzic A</searchLink>; Division of Medicine, University of Nottingham, Nottingham, NG5 1PB, UK.<br /><searchLink fieldCode="AU" term="%22Lajeunesse+Trempe+F%22">Lajeunesse Trempe F</searchLink>; Institut Universitaire de Cardiologie Et de Pneumologie de Québec, Québec, QC, Canada.; Faculty of Pharmacy, Laval University, Quebec, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Stanley+M%22">Stanley M</searchLink>; Helier Hospital, Sutton, UK.<br /><searchLink fieldCode="AU" term="%22Bhatti+A%22">Bhatti A</searchLink>; Nottingham University Hospitals, University of Nottingham, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Scragg+J%22">Scragg J</searchLink>; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Badawy+L%22">Badawy L</searchLink>; Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Moqeem+K%22">Moqeem K</searchLink>; Kings College Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Idris+I%22">Idris I</searchLink>; University of Nottingham, Nottingham, UK.; University Hospitals of Derby & Burton FT, Derby, UK.<br /><searchLink fieldCode="AU" term="%22Andrews+RC%22">Andrews RC</searchLink>; University of Exeter Medical School, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Sen+Gupta+P%22">Sen Gupta P</searchLink>; Guy's and St Thomas's Hospitals NHS Trust, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Hughes+D%22">Hughes D</searchLink>; University Hospitals of Derby & Burton FT, Derby, UK.<br /><searchLink fieldCode="AU" term="%22McCullough+K%22">McCullough K</searchLink>; Royal Surrey Hospital NHS Trust, Guildford, UK.; Ashford and St Peter's Hospital NHS Trust, Surrey, UK.; Royal College of Physicians, London, UK.; NHS England, London, UK.<br /><searchLink fieldCode="AU" term="%22Tan+T%22">Tan T</searchLink>; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, W12 0HS, UK.<br /><searchLink fieldCode="AU" term="%22McGowan+B%22">McGowan B</searchLink>; Guy's and St Thomas's Hospitals NHS Trust, King's College London, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101578283%22">Current obesity reports</searchLink> [Curr Obes Rep] 2026 Apr 02; Vol. 15 (1). <i>Date of Electronic Publication: </i>2026 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Current+Medicine+Group%22">Current Medicine Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101578283 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-4968 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624968%22">21624968 </searchLink><i>NLM ISO Abbreviation: </i>Curr Obes Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41922811 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s13679-026-00707-6 Languages: – Code: eng Text: English Titles: – TitleFull: The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Albor C – PersonEntity: Name: NameFull: Anyiam O – PersonEntity: Name: NameFull: Boyle LD – PersonEntity: Name: NameFull: Makaronidis J – PersonEntity: Name: NameFull: Tan R – PersonEntity: Name: NameFull: Iftikhar S – PersonEntity: Name: NameFull: Burzic A – PersonEntity: Name: NameFull: Lajeunesse Trempe F – PersonEntity: Name: NameFull: Stanley M – PersonEntity: Name: NameFull: Bhatti A – PersonEntity: Name: NameFull: Scragg J – PersonEntity: Name: NameFull: Badawy L – PersonEntity: Name: NameFull: Moqeem K – PersonEntity: Name: NameFull: Idris I – PersonEntity: Name: NameFull: Andrews RC – PersonEntity: Name: NameFull: Sen Gupta P – PersonEntity: Name: NameFull: Hughes D – PersonEntity: Name: NameFull: McCullough K – PersonEntity: Name: NameFull: Tan T – PersonEntity: Name: NameFull: McGowan B IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 04 Text: 2026 Apr 02 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2162-4968 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Current obesity reports Type: main |
| ResultId | 1 |
